GHRP-6 vs Hexarelin
A side-by-side research comparison of GHRP-6 and Hexarelin across mechanism, dosing, half-life, benefits, side effects and research status.
Comparison table
| Attribute | GHRP-6 | Hexarelin |
|---|---|---|
| Full name | Growth Hormone Releasing Peptide-6 | Hexarelin (Examorelin) |
| Category | Growth Hormone | Growth Hormone |
| Status | Research compound | Research compound |
| Mechanism | Activates GHSR-1a on pituitary for GH release and hypothalamic neurons for appetite. Triggers gastric motility and ghrelin-like reward signaling. | Potent GHSR-1a agonist producing maximal pituitary GH output. Additionally binds cardiac CD36, providing cardioprotection through anti-apoptotic mechanisms independent of GH. |
| Molecular weight | 873 Da | 887 Da |
| Half-life | 2-3 hours | 1-2 hours |
| Bioavailability | High (SubQ) | High (SubQ) |
| Typical dose | 100-300 mcg | 100-200 mcg |
| Frequency | 2-3x daily | 2-3x daily |
| Route | Subcutaneous | Subcutaneous |
GHRP-6 reported benefits
- Strong GH release
- Powerful appetite stimulation
- Gastric motility improvement
- Recovery enhancement
- Gut healing support
Hexarelin reported benefits
- Strongest GH release
- Cardioprotective effects
- Recovery acceleration
- Anti-fibrotic (cardiac)
- Neuroprotective potential
Related comparisons
Research and educational reference only. Not medical advice.